BBVA USA Bancshares’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
$442K Sell
17,338
-583
-3% -$14.9K 0.02% 413
2020
Q4
$440K Sell
17,921
-3,339
-16% -$62.7K 0.02% 407
2020
Q3
$346K Buy
21,260
+327
+2% +$6.08K 0.02% 418
2020
Q2
$358K Buy
20,933
+642
+3% +$9.52K 0.02% 416
2020
Q1
$236K Buy
20,291
+6,258
+45% +$129K 0.02% 437
2019
Q4
$390K Buy
14,033
+3,409
+32% +$85.5K 0.02% 406
2019
Q3
$240K Buy
10,624
+2,028
+24% +$46.2K 0.02% 341
2019
Q2
$217K Sell
8,596
-1,635
-16% -$43.9K 0.01% 500
2019
Q1
$278K Buy
10,231
+1,068
+12% +$35.8K 0.02% 452
2018
Q4
$303K Sell
9,163
-2,325
-20% -$93.5K 0.02% 415
2018
Q3
$536K Sell
11,488
-1,690
-13% -$77.6K 0.03% 376
2018
Q2
$570K Sell
13,178
-4,041
-23% -$194K 0.04% 348
2018
Q1
$958K Buy
17,219
+947
+6% +$51.9K 0.06% 264
2017
Q4
$870K Sell
16,272
-982
-6% -$46.3K 0.06% 290
2017
Q3
$744K Sell
17,254
-2,005
-10% -$95.3K 0.05% 311
2017
Q2
$1.16M Sell
19,259
-2,323
-11% -$138K 0.08% 240
2017
Q1
$1.5M Sell
21,582
-1,362
-6% -$94.6K 0.1% 194
2016
Q4
$1.53M Buy
22,944
+552
+2% +$35.9K 0.11% 179
2016
Q3
$1.48M Sell
22,392
-236
-1% -$16.1K 0.11% 181
2016
Q2
$1.64M Sell
22,628
-12,124
-35% -$833K 0.12% 168
2016
Q1
$2.25M Sell
34,752
-16,902
-33% -$1.12M 0.17% 135
2015
Q4
$3.7M Buy
51,654
+45
+0.1% +$3.33K 0.28% 95
2015
Q3
$3.96M Buy
51,609
+3,102
+6% +$250K 0.31% 89
2015
Q2
$3.6M Buy
48,507
+1,547
+3% +$111K 0.2% 128
2015
Q1
$3.4M Buy
46,960
+1,863
+4% +$130K 0.15% 166
2014
Q4
$2.98M Buy
45,097
+2,719
+6% +$166K 0.14% 167
2014
Q3
$2.32M Buy
42,378
+9,826
+30% +$557K 0.1% 179
2014
Q2
$1.89M Buy
32,552
+12,552
+63% +$739K 0.08% 206
2014
Q1
$1.24M Buy
20,000
+8,063
+68% +$469K 0.06% 238
2013
Q4
$638K Buy
11,937
+499
+4% +$26.8K 0.03% 324
2013
Q3
$574K Sell
11,438
-426
-4% -$20.8K 0.03% 312
2013
Q2
$543K Buy
+11,864
New +$531K 0.03% 306

Other funds holding MD

BBVA USA Bancshares's MD Position: Q1 2021 in Review

BBVA USA Bancshares reduced its Pediatrix Medical (MD) stake by 3.3% in Q1 2021, selling an estimated $14.9K and leaving 17,338 shares worth $442K. The position accounts for 0.02% of the portfolio, ranked #413.

BBVA USA Bancshares first reported a position in MD in Q2 2013 and has held it in 32 quarters since. The position peaked at $3.96M in Q3 2015. 207 funds tracked by Wall St. Rank hold MD as of Q1 2021.

  • BBVA USA Bancshares held 17,338 shares of Pediatrix Medical worth $442K as of Q1 2021.
  • BBVA USA Bancshares sold 583 Pediatrix Medical shares in Q1 2021, an estimated $14.9K.
  • Pediatrix Medical made up 0.02% of BBVA USA Bancshares's portfolio in Q1 2021, its #413 holding.
  • BBVA USA Bancshares first reported a position in Pediatrix Medical in Q2 2013 and has held it in 32 quarters since.
  • BBVA USA Bancshares's Pediatrix Medical position peaked at $3.96M in Q3 2015.
  • 207 funds tracked by Wall St. Rank held Pediatrix Medical as of Q1 2021.

Based on BBVA USA Bancshares's 13F filing for Q1 2021, filed 23 Apr 2021.